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The concept of economic profit (EVA 1 ) has proved successful in the field of corporate finance
since its adoption by several U.S. and International companies over the past 25 years. Unlike
accounting earnings, EVA is a measure of a company’s true earnings because it fully “accounts”
for the costs of all forms of financing, including debt and equity. In the EVA view, a company is
not truly profitable unless it earns a return on capital that bests the opportunity cost of capital.
That being said, the question that we address here is how to measure the economic profit of
providers in the healthcare sector, which is largely comprised of Not-for-Profit organizations
such as clinics, laboratories, and hospitals. 2
We’ll begin the EVA journey for healthcare providers by abstracting from the myriad of
accounting adjustments that can be made to estimate EVA and instead look at how to estimate
“basic” economic profit in both For Profit (the traditional realm for EVA application) and Notfor-Profit settings. The financial goal here is twofold: (1) to illustrate the key ingredients of
economic profit for healthcare providers without getting tangled up in a web of accounting
adjustments and, (2) to illustrate the advantage of using economic profit over traditional
accounting profit measures such as operating margins and net income.
We’ll then discuss the concept of “disclosed” EVA for healthcare providers, which
reflects income statement and balance sheet effects of several value-based accounting
adjustments to economic profit. These EVA accounting adjustments include the traditional ones
identified by Stewart 3 ; such as the EVA treatment of research and development expenditures,
inventory costing (LIFO/FIFO), lease expense, restructuring costs, and conversion from reported
income taxes to cash operating taxes (For-Profit companies).
In turn, we’ll examine unique EVA accounting adjustments for healthcare providers
(applicable to both For-Profit and Not-for-Profit healthcare organizations). These include (1)
2

income statement adjustments for changes in net charity care (net uncompensated care)
expenditures 4 , medical training costs, and community wellness and prevention program costs,
and (2) the corresponding EVA balance sheet adjustments which reflect the capitalization of
provider-based intangibles as equity equivalents, particularly “net asset” or “fund equity”
equivalents in the case of Not-for-Profit healthcare providers. 5

BASIC EVA
For-Profit Provider
We’ll begin by estimating EVA in the traditional For-Profit setting. We can then make taxrelated adjustments to this framework that would apply to the predominance of healthcare
providers in the Not-for-Profit sector of the economy. In this context, there are two basic
ingredients to estimating EVA—namely, NOPAT, which stands for net operating profit after tax,
and $WACC, which is the dollar cost of invested capital. We’ll start with NOPAT.
In the absence of EVA accounting adjustments, a For-Profit provider’s net operating
profit after tax can be expressed in terms of its tax-adjusted earnings before interest and taxes,
EBIT, according to: 6

NOPAT = EBIT–Cash Taxes
=EBIT x (1-t)
= [R-COMS-SG&A-D] x (1-t)

In this expression, EBIT x (1-t) is the provider’s NOPAT. This EVA term is a reflection of the
provider’s earnings before interest and taxes, EBIT, less its unlevered business taxes. 7 Likewise,
3

the terms, R, COMS, and SG&A in the NOPAT formulation refer to the provider’s Net Revenue,
Cost of Medical Services, and Selling, General and Administrative Expenses, respectively. In
principle, the depreciation term, D, should be a charge that reflects the economic obsolescence of
the provider’s assets. In turn, the dollar cost of capital, $WACC, can be expressed as:

$WACC = WACC x C

In this expression, WACC is the weighted-average cost of debt and equity capital (expressed as a
required rate in decimal form), and C is the provider’s net operating capital. In turn, the weighted
average capital cost, WACC, is given by:

WACC = After-tax Debt Cost x Debt Weight
+ Equity Cost x Equity Weight

Taken together, these developments show that a For Profit provider’s EVA can be expressed in
basic terms as:

EVA = NOPAT - $WACC
= EBIT x (1-t) – WACC x C
= [R-COMS-SG&A-D] x (1-t) – WACC x C

The basic EVA formula shows that a For Profit provider’s economic profit is equal to its
net operating profit after tax less the dollar cost of all capital employed within the organization.
4

In the next section, we’ll look at a simple income statement and balance sheet for a hypothetical
For-Profit provider to illustrate how to measure basic EVA. We’ll then look at the adjustments to
basic EVA that need to be made in the Not-for-Profit setting. Along the way, we’ll discuss the
ways to increase EVA to improve organization efficiency and to enhance organizational value.
We’ll conclude our EVA journey by explaining the concept of “disclosed” EVA, which reflects
both traditional and unique accounting adjustments that apply in both For Profit and Not-forProfit healthcare settings.

“OK-HEALTH” Provider
We’ll now illustrate how to measure basic EVA for a For-Profit provider called “OK Health.”
The goal here is to see if OK Health is in fact “okay” from an economic profit perspective. 8
We’ll then explain the tax adjustments to basic EVA that are necessary if instead OK Health
were a Not-for-Profit clinic, hospital, or laboratory. To begin, Exhibits 1 and 2 show the income
statement and balance sheet respectively for OK Health at a point in time.
When viewing OK Health’s financial statements from an accounting perspective, it
appears that it is a profitable healthcare provider. Based on the income statement shown in
Exhibit 1, OK Health reports a positive gross margin, at 31.2% (39,000/125,000), and a positive
operating margin, at 13.6% (17,000/125,000). 9 As a For Profit provider, OK Health’s net
income and operating earnings per share are also positive, at $8,213 and $1.31, respectively. In
turn, with Stockholder’s Equity at $96,600 its return on equity (ROE) seems favorable, at 8.5%
(8,213/96,600 x 100). Moreover, based on the “Dupont formula,” the provider’s ROE results
from multiplying its return on assets, ROA at 5.4%, by the equity multiplier (Assets/Equity) of
1.57. 10
5

OK Health’s Economic Profit

To see if OK Health is truly a profitable healthcare provider—that is, a value creator in financial
terms—we’ll first calculate the provider’s net operating profit after tax, NOPAT. Upon
substituting the provider’s Net Revenue, Cost of Medical Services, Selling General and
Administrative, and tax rate figures into the NOPAT formulation, we obtain: 11

NOPAT = [R-COMS-SG&A] x (1-t)
= [125,000-86,000-22,000] x (1-0.4)
= 17,000 x 0.6 = $10,200

In order to measure OK Health’s dollar cost of capital, the manager needs to know something
about (1) the after-tax cost of debt, (2) the cost of equity capital, and (3) the “target” debt weight,
if any, in the capital structure, and (4) the dollar amount of capital employed in its healthcare
organization. 12 With respect to the first requirement, OK Health’s after-tax cost of debt can be
estimated according to:
After-tax Debt Cost = Pre-tax Debt Cost x (1-t)
= 0.08 x (1-0.4)
= 0.048 or 4.8%

In this expression, the pre-tax debt cost, at 8%, is taken as the provider’s average coupon rate on
the balance sheet (for simplicity, we assume that the provider’s bonds are trading at par value).
OK Health’s pre-tax borrowing cost of 8% can also be obtained by dividing the provider’s
6

interest expense, $3,312 (income statement), by the face value of its long term debt, at $41,400
(balance sheet).
In turn, we’ll use the Capital Asset Pricing Model to estimate OK Health’s cost of
equity. 13 With a risk-free interest rate of 6.5%, a market-driven equity risk premium of 6%, and a
common stock beta of 1.0, the provider’s (CAPM-based) cost of equity capital becomes: 14

CAPM = Rf + MRP x Beta
= 0.065 + 0.06 x 1.0
= 0.125 or 12.5%

Moreover, if we assume that OK Health’s “target” debt-to-capital ratio is 30%, the provider’s
overall cost of capital can be measured according to:
WACC = After-tax Debt Cost x Debt Weight
+ Equity Cost x Equity Weight
= 0.048 x (0.3) + 0.125 x (0.7)
= 0.102 or 10.2%

Repackaging the Balance Sheet
With knowledge of OK Health’s operating capital it is possible to calculate the dollar cost of
capital, $WACC. In this context, it is helpful to recognize that the provider’s balance sheet can
be “repackaged” in a way that shows the equivalency of its operating and financing capital.
Exhibit 3 illustrates this result.

7

Exhibit 3 shows that OK Health’s operating and financing capital is $138,000. The
operating capital (left hand side of balance sheet) is equal to net working capital (excluding debtrelated short term accounts) plus net plant, property and equipment (as well as other operating
assets). Likewise, in the absence of EVA accounting adjustments, the financing capital is just
long-term debt (including short-term debt accounts, minority interest, and capitalized lease
obligations, if any) plus stockholders’ equity (including both preferred and common equity).
Hence, the provider’s overall dollar-cost of capital can be measured by applying the weighted
average cost of capital, at 10.2%, to either the provider’s tangible operating capital or its
equivalent financing sources of capital. Whatever side of the EVA balance sheet is chosen, OK
Health’s dollar cost of capital is $14,076:
$WACC = WACC x C
= 0.102 x 138,000
= $14,076

More importantly, since OK Health’s dollar cost of financing, $WACC, is higher than its net
operating profit after tax, NOPAT, the healthcare provider has negative economic profit:

EVA = NOPAT - $WACC
= 10,200 - 14,076
= -$3,876

Thus, while OK Health looks like a profitable healthcare producer from a traditional accounting
perspective, the EVA insight reveals that the provider is a (potential 15 ) value destroyer. This
8

happens because its operating profitability is not sufficient enough to cover the overall dollar
cost of capital.

OK Health’s Residual Return on Capital
We can also show that OK Health has negative EVA because its underlying “residual (or
surplus) return on capital”, RROC, is negative. This value wasting situation occurs when a
provider’s after-tax return on capital, ROC, falls short of the weighted average capital cost,
WACC. To illustrate this, simply define RROC as the provider’s EVA-to-Capital ratio. At 2.8%, one sees that OK Health’s adverse surplus return on capital is caused by its negative
economic profit:

RROC = EVA/Capital
= -3,876/138,000
= -0.028 or -2.8%

Likewise, since EVA can be expressed as the provider’s initial capital, C, times the residual
return on capital, RROC, the same result is obtained by focusing on the spread between the aftertax return on capital, ROC, and the weighted average cost of debt and equity capital, WACC: 16

RROC = EVA/C
= [ROC - WACC]
= [0.074 - 0.102] = -0.028
= -0.028 or -2.8%
9

In this expression, ROC, at 7.4%, results from dividing NOPAT, $10,200, by the provider’s
capital, $138,000. The WACC is the familiar cost of capital percentage of 10.2%.

OK Health’s Interest Tax Subsidy
When looking at OK Health as a For Profit provider, it is important to use its net operating profit
after tax, NOPAT in the first step of the EVA calculation. This is because the dollar cost of
capital (step two of the EVA calculation) already reflects the interest tax subsidy received on the
provider’s outstanding debt obligations. By double counting this debt-induced tax subsidy, the
manager or analyst would not only overestimate the provider’s operating profit, but he or she
would also impart a positive bias in the provider’s organizational value (enterprise value in the
traditional for-profit realm of corporate valuation).
To show the source of bias, it is helpful to note that the “levered” provider’s net operating
profit after tax, LNOPAT, can be expressed in terms of the equivalent risk “unlevered”
provider’s net operating profit, NOPAT, plus a yearly interest tax subsidy. Looking at OK
Health in this levered (with debt) and unlevered (without debt) context yields:

LNOPAT = NOPAT + t x Interest
= $10,200 + 0.4 x $3,312
= $10,200 + $1,325
= $11,525

10

In this expression, t x Interest (at $1,325), is the yearly interest tax subsidy that OK Health
receives as a For-Profit levered provider, as opposed to a For-Profit debt-free provider. However,
this same interest tax benefit is already reflected in the provider’s dollar cost capital cost through
the reduced cost of corporate debt financing.
To show this, recall that OK Health’s after tax cost of debt was previously expressed as:
After-tax debt cost = Pre-tax debt cost x (1-t)
= 0.08 x (1-0.4)
= 0.048 or 4.8%

In this formulation, the provider’s pre-tax cost of debt, 8%, is reduced by 320 basis points due to
the tax benefit that OK Health receives from deductibility of its debt interest expense. Expressing
this leverage-induced reduction in the For-Profit provider’s dollar cost of capital yields the same
yearly interest tax benefit that is already reflected in the provider’s levered operating profit:

$WACC Tax Subsidy = t x [Pre-tax Debt Cost] x Debt
= 0.4 x [3,312/41,400] x 41,400
= $1,325

To avoid positive bias, OK Health’s economic profit must be calculated by first
estimating what its net operating profit after tax, NOPAT, would be as an equivalent risk
unlevered provider--namely, an “OK Health like” provider with no debt--and then subtracting
the overall dollar cost of debt and equity capital from this unlevered NOPAT figure.

11

BASIC EVA
Not-for-Profit Provider
There are several issues that arise when measuring EVA in a Not-for-Profit setting. The first is
obvious: NOPAT and $WACC must be stated on a pre-tax basis, which we’ll address shortly. A
second and more fundamental issue arises in the interpretation of the pre-tax cost of debt and the
cost of equity for Not-for-Profit providers. With respect to debt financing, the pre-tax cost of
debt should be interpreted as the yield to maturity on an equivalent-risk, tax-exempt bond issued
by a local, regional, or state healthcare authority.
In the case of equity financing, we can interpret this cost as a cost of “fund” equity. 17
With that view, the opportunity cost of equity for a Not-for-Profit provider equals the “grossed
up” equity cost of a For-Profit provider. This is due to the fact that CAPM (one measure of
equity cost) is an after-tax rate and Not-for-Profits do not pay taxes (typically) on operating
income. In principle, the pre-tax CAPM can be interpreted as a cost of fund equity because the
perceived benefits from donor contributions (fund equity) can be viewed in financial terms as
being worth what a charitable giver or donor could have earn on a similar risk portfolio of
investment securities. The same opportunity cost concept applies in the case of retained earnings
by Not-For-Profit organizations; as equity capital in For Profit and Not-for-Profit settings is not
“free capital”. Also, another issue that arises when measuring EVA for Not-for-Profits involves
“equity equivalents”. We’ll address unique equity equivalents for providers-such as the
capitalized values of charity care (net), medical training costs, and community wellness and
prevention programs costs-at a later point.
There are of course tax adjustments to NOPAT and $WACC that must be made when
estimating EVA in the Not-for-Profit setting. If, for example, we measure OK Health’s EVA on
12

a pretax basis-because (1) the healthcare manager wants to make a comparison of operating
performance with a Not-for-Profit provider, or (2) because OK Health is actually a Not-for-Profit
provider--then we need to estimate EVA components (NOPAT and $WACC) on a pre-tax basis.
In this context, the healthcare provider’s net operating profit before taxes, NOPBT, would be
used in conjunction with a pre-tax dollar cost of capital.
To see how this works, we can express OK Health’s net operating profit before tax as:

NOPBT = NOPAT/(1-t)
= EBIT x (1-t)/(1-t)
= EBIT = $17,000

In turn, the provider’s weighted average cost of capital must be expressed on a pre-tax basis. The
only complication here is that the after-tax cost of equity needs to be “grossed up” by one minus
the (marginal) corporate tax rate to convert it to a pre-tax fund-equity rate.

Pre-tax WACC = Debt Weight x Pre-tax Debt Cost
+ Equity Weight x Pre-tax Equity Cost
= 0.3 x [0.048/(1-0.4)] + 0.7 x [0.125/(1-0.4)]
= 0.3 x 0.08+ 0.7 x 0.208
= 0.17 or 17%
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In this context, OK Health’s pre-tax cost of debt is 8% (same as coupon rate assuming that bonds
are trading at par), its pre-tax cost of equity (fund equity) is 20.8%, and its pre-tax cost of capital
is 17%. With this development, the healthcare provider’s pre-tax EVA is:

Pre-tax EVA = Pre-tax NOPAT - Pre-tax $WACC
= EBIT - Pretax WACC x C
= $17,000 - 0.17 x $138,000
= $17,000 - $23,460
= -$6,460

Not surprisingly, OK Health’s pre-tax EVA is equal to its after-tax EVA grossed up by one
minus the corporate tax rate, t:

Pretax EVA = After Tax EVA/(1-t)
= -$3,876/(1-0.4)
= -$6,460

Role of Capital Efficiency
It is well known that capital efficiency is essential for creating value within any organization.
EVA emphasizes capital efficiency through improved working capital management (for
example, a “just-in-time” inventory system) and/or better utilization of assets including medical
facilities and technology. To see this, we can express the return on capital as a NOPAT margin
times a capital turnover ratio:
14

ROC = NOPAT/C
= NOPAT/R x R/C
=NOPAT/R x R/(NWC+NPPE)

Clearly, anything a manager can do to increase a provider’s net operating margin (NOPAT/Net
Revenue) will lead to a higher return on capital. Other things the same, anything a manager can
do to earn more revenue for a given amount of capital--or use less capital (net working capital
and net plant property and equipment) for a given amount of revenue—will produce a higher
return on capital. Upon substituting the appropriate ROC figures for OK Health as a Not-forProfit provider we obtain:

Pre-tax ROC = EBIT/R x R/C
=$17,000/$125,000 x $125,000/$138,000
= 0.136 x 0.91
= 0.123 or 12.3%

Thus, better capital turns [1/(NWC+NPPE)] at OK Health are needed because its pre-tax cost of
capital, at 17%, is higher than its pre-tax return on capital. In its status quo position, we see that
OK Health is hardly “OK” from an EVA perspective, even though its return on capital, at 12.3%
is positive and seems attractive from a more traditional accounting perspective.

15

Accounting versus EVA
Break Even Point
We can also distinguish between the breakeven numbers of patients (units) that a provider would
need to produce a zero accounting profit versus a value-based measure of breakeven, namely,
zero economic profit. Specifically, the traditional accounting breakeven point for a provider is
given by:
:
A-BEP = FC/(p-v)

In this expression, FC is fixed costs, which from a managerial accounting perspective includes
the fixed cost components of COMS and SG&A. In turn, p refers to a composite average price
charged per patient service and v is the variable cost per patient for medical services supplied. If
we assume that (1) fixed costs make up 25% of COMS ($86,000) and SG&A ($22,000)
respectively, (2) the price per unit of patient medical services is $250.00, and (3) variable
medical costs per patient service is $150.00, then the per-period A-BEP for OK Health is:

A-BEP = 0.25 x $108,000/($250-$150)
=$27,000/100 = 270 patients

From an EVA perspective FC includes accounting fixed costs plus a fixed target dollar return.
With EVA, the minimum acceptable dollar return to debt holders and fund equity contributors is
$WACC. Upon substituting OK Health’s pre-tax dollar cost of capital into FC, we obtain the
break even number of patients in pre-tax EVA terms:
16

E-BEP = ($27,000+$23,460)/($250-$150)
= $50460/100 = 505 patients

Thus, a healthcare provider must supply medical services (achieved possibly through
“outsourcing” medical services) to a larger network with more payer patients in order to
breakeven in economic profit terms. This is because EVA emphasizes the importance of the cost
of capital, particularly equity capital in the For-Profit setting and fund equity in a Not-for-Profit
setting. In the absence of showing a breakeven number of patients in economic terms, a provider
will have difficulty attracting new capital to invest in the latest medical technology advances.
Worse yet, an unprofitable provider would be faced with aging facilities falling into disrepair.

OK Health’s Growth Opportunities
Given that OK Health has negative EVA, it has a clear incentive to find a positive growth
opportunity. In this context, let’s suppose that the provider discovers that it can invest $20,000 in
a new medical technology that will increase yearly patient revenue by $40,000. In turn, suppose
that OK Health’s Cost of Medical Services and Selling, General, and Administrative Expense
accounts rise by $25,000 and $5,000 per annum, respectively. With these assumptions, the
provider’s estimated annual NOPAT will go up by $6,000 18 :

ΔNOPAT = Δ[R-COMS-SG&A] x (1-t)
= [40,000-25,000-5,000] x (1-0.4)
= $6,000
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Since OK Health’s operating capital rises by $20,000 to support the higher revenue
forecast, its estimated (annual) capital costs rise by $2,040:

Δ$WACC = WACC x ΔC
= 0.102 x 20,000
= $2,040

Taken together, the changes in NOPAT and $WACC reveal that OK Health’s growth
opportunity is a desirable investment for its owners. 19 With these figures, OK Health’s EVA
rises by $3,960 per annum:

ΔEVA = ΔNOPAT - Δ$WACC
= $6,000 - $2,040
= $3,960

As a result of OK Health’s medical technology opportunity, we see that the provider has
moved from a value-destroyer to a value-neutral position. Among other things, this implies that
the provider’s revised return on capital, 10.3% (16,200/158,000), is now close to the overall cost
of capital, 10.2%. Likewise, in this value neutral situation, the provider’s residual return on
capital, RROC, is nearly zero. Of course, with further growth opportunities, OK Health has the
potential to become a value creator with discounted positive economic profit. Without getting
into details here, one can also assess the valuation consequences of OK Health’s growth
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opportunities, including an estimate of its stock price as a For Profit provider or its equivalent
“shadow” price as a Not-For Profit. 20

WAYS TO INCREASE EVA
We now see that EVA is helpful for healthcare providers because it gives a transparent look at
key features of economic profit measurement. In this context, EVA reveals that a provider is not
economically profitable until it covers its usual operating expenses and all of its financing
costs—including the dollar cost of debt and equity (however interpreted). In this sense, EVA is
superior to accounting profit measures such as operating margins and net income. Additionally,
we can use basic EVA to gain insight on the financial steps that providers must take to
permanently improve their economic profit outlook and, thereby, enhance enterprise value.
There are several ways that a provider can improve its economic profit outlook. 21
Specifically, the basic EVA formula suggests that value conscious providers should take steps to:
•

Increase net revenue (patients, or otherwise)

•

Reduce operating expenses (COMS and SG&A) where prudent

•

Use less capital to produce the same amount of medical services (improved asset turns)

•

Use more capital to invest in positive growth opportunities (medical facilities, training,
and community service “investments” that build brand image)

•

Reduce WACC

Expanding a provider’s market share is captured by increasing net revenue in the EVA formula.
Other things the same (operating expenses and capital costs), higher revenue means higher
economic profit. Also, it should be no surprise that reducing a provider’s operating expenses via
19

cost cutting and/or achieving tax efficiency enhances economic profit because the COMS,
SG&A and cash tax accounts go down. 22 However, when using cost cutting as a tool to improve
the EVA outlook, providers must be cautioned that too much cost cutting, “cuts” the fabric of its
future economic profit, or worse yet, the quality of its medical services.
Note that if EVA is to be taken seriously as an improvement over traditional accounting
profit measures then it must do more than just show that increasing revenue and/or reducing
operating expenses will improve a provider’s organizational value. Fortunately, this is where
economic profit and accounting profit measurement depart since EVA fully “accounts” for the
dollar cost of capital in terms of both the amount of capital employed and the opportunity cost of
that capital.
EVA emphasizes the rationalization of capital as can be seen in the basic EVA
formulation. Clearly, anything that providers can do to (1) improve inventory and net PP&E
(Plant, Property and Equipment) turnover ratios from the balance sheet, and (2) reduce business
uncertainty (as manifest in a decline in NOPAT volatility) will have beneficial cost of capital
implications via the impact on C and WACC, respectively. Moreover, we used the basic EVA
formula to show that investing more capital (rather than less capital) in positive economic profit
growth opportunities is really what value creation is all about.
Also, EVA links the income statement and balance sheets with a value-based focus on net
operating profit after tax and invested capital. Unlike accounting profit, EVA measures the dollar
cost of capital by multiplying the amount of capital by the overall cost of capital. Hence, EVA
measures profit in the classical economists’ notion of “profit” because a providers’ opportunity
cost of capital is fully reflected in the profit calculation. 23 Since accounting profit “accounts”
only for the dollar cost of debt financing, via interest expense, it completely misses the dollar
20

cost of equity capital. This cost of financing omission is important for providers that finance their
growth opportunities with (fund) equity—particularly providers that make substantial
investments in tangibles (medical facilities and technology) and intangibles (net charity care,
medical training, and community wellness and prevention programs as described below) as well
as providers that seek to expand their market share in a cost efficient manner.

DISCLOSED EVA
Before concluding, it is important to understand the role of EVA-based accounting adjustments,
with an eye toward those adjustments that are unique to healthcare providers. To begin, Bennett
Stewart provides a “generally accepted” boilerplate of accounting adjustments that are necessary
to estimate a company’s NOPAT and invested capital 24 In this context, Exhibit 4 shows
traditional accounting adjustments that are used in the equivalent “bottom-up and top-down”
approaches to estimating a company’s “disclosed” NOPAT, while Exhibit 5 shows capital
adjustments employed in the “asset and financing” approaches to estimating disclosed capital.
Additionally, the two exhibits show unique accounting adjustments used in measuring disclosed
EVA for healthcare providers.

Disclosed NOPAT

In the bottom-up approach to measuring disclosed NOPAT (Exhibit 4 Panel A), the
provider begins with net operating profit before taxes (using For-Profit terminology). This is just
operating earnings before interest and taxes (EBIT) on a provider’s income statement. 25 To this
amount, several EVA-based accounting adjustments are made to move toward a better
representation of the firm’s pre-tax cash operating profit. For examples, the increase in LIFO
21

reserve account is added to operating profit to adjust for the overstatement of cost of goods
sold—due to overstatement of product costing--in a period of rising prices (inflation), while the
increase in capitalized research and development (or change in Unamortized R&D account on
EVA balance sheet) is added back to operating profit to recognize that R&D costs should be
capitalized (rather than expensed in the year incurred) because they generate a future stream of
cash flow benefits. 26
Likewise, the increase in accumulated goodwill amortization (described in footnotes to
financial statements) is added to operating profit to reflect that goodwill (in the EVA view) is a
form of capital investment that needs to earn a cost of capital return just like expenditures on
physical capital. Goodwill intangibles are particularly poignant for healthcare providers like
hospitals and clinics because expenditures on “charity care” and community wellness and
prevention programs are key elements to fulfilling the community service mission of both Notfor-Profit and For Profit providers. Also, Stewart argues that the increase in bad debt reserve
should be added back to pre-tax operating profit to more accurately reflect a company’s
experience default rate on consumer receivables. However, since the rise in capitalized net
charity care is treated separately on the EVA income statement, the change in bad debt reserve
pertains only to financially able payers that refuse to pay their healthcare obligations.
Panel A of Exhibit 4 also shows that implied interest expense on operating leases is
added back to operating results to remove the capital structure effects of debt-related financing
decisions. Also, the rise in reengineering and/or restructuring costs (write-offs of special items)
in the typical For Profit setting is added to operating profit as well as the rise in system network
development costs for multi-hospital providers or like healthcare providers; in the EVA view
these expenditures are treated as capital “investments.” Moreover, in the case of For-Profit
22

providers (because Not-for-Profits do not usually pay taxes), cash operating taxes, rather than
reported income taxes, is subtracted from pre-tax operating earnings to arrive at disclosed
NOPAT. Panel B of Exhibit 4 shows the top-down approach to estimating provider disclosed
EVA, which should now be self explanatory.

Disclosed Capital
In the assets approach (Exhibit 5 Panel A) to estimating disclosed capital, the provider begins
with net short term operating assets (net working capital less short-term debt equivalents). This
reflects moneys tied up in current assets like accounts receivables and inventories as well as a
normal amount of cash needed for operations. 27 Current liabilities such as accounts payable,
accrued expenses, and income taxes payable (For-Profit provider) are netted from the short term
operating asset accounts. Short-term notes payable (a current liability account) are excluded from
this calculation because they represent a source of debt financing. Interest-bearing debt is
reflected in the sources of financing approach (Panel B Exhibit 5) to measuring disclosed capital,
while the debt-interest tax subsidy (For-Profit provider) is reflected in the calculation of a
company’s dollar cost of capital.
Net plant, property, and equipment and goodwill (particularly, acquisition goodwill) are
then added to net short term operating assets. Special attention should be paid to unamortized
medical intangibles that are unique to the mission of healthcare providers. These unique “assets”
include the capitalized (unamortized) values of net charity care, medical training expenditures,
and community wellness and prevention program costs that are essential to a provider’s
community service mission. 28 Several other “equity equivalents” are added to invested capital;
these include LIFO Reserve, accumulated goodwill amortization, net capitalized research and
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development, cumulative bad debt reserve, the cumulative write-off of special items like
reengineering and restructuring costs, as well as the capitalized value of system-wide
development and networking costs in multi-hospital settings. Moreover, the present value of
operating leases (better dubbed leased operating assets) is added back to arrive at disclosed
capital on the EVA balance sheet.
In the sources of financing approach (Exhibit 5 Panel B), the healthcare provider begins
with Stockholder’s Equity in the For-Profit setting or “Net Assets” in the Not-for-Profit setting.
To this amount, one adds “equity equivalents” including those already listed on a provider’s
balance sheet—such as preferred stock, minority interest, and deferred income taxes (For-Profit
setting)--as well as the companion equity equivalent accounts mentioned above in the equivalent
assets approach to estimating disclosed capital—namely, traditional equity equivalents including
LIFO reserve, accumulated goodwill amortization, net capitalized research and development, bad
debt reserve, and the cumulative write-offs of special items; as well as the capitalized value of
provider-based intangibles such as net charity care, medical training expenditures, and related
goodwill.
In turn, debt and debt equivalents are then added to arrive at disclosed capital in the
sources of financing approach. These debt-related accounts include those listed on the balance
sheet--including interest bearing short-term debt, long-term debt, and capitalized lease
obligations—and “off balance sheet” debts 29 such as projected operating lease rentals (typically
four-to-five year projections) in terms of their present value equivalent. With recognition of
several EVA-based accounting adjustments, we see that the equivalent asset and financing
approaches to estimating disclosed capital produce a robust measure (compared with basic EVA
explained earlier) of economic capital. That being said, a healthcare provider must (still)
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consistently earn a return on capital that bests the opportunity cost of capital in order to be a
value creator with discounted positive economic profit.

SUMMARY
We looked at how to estimate basic economic profit for healthcare providers and we concluded
with some unique EVA accounting adjustments that result in disclosed EVA; these unique
accounting adjustments include the capitalized (unamortized) values of net charity care, medical
training expenditures, and community wellness and prevention program costs that are key to
fulfilling a provider’s community service mission. We focused initially on basic EVA in order to
abstract from a myriad of value-based accounting adjustments and instead look at the key
features of economic profit measurement. We asserted that EVA is consistent with the
economists’ notion of “profit” because it measures profitability net of both the usual operating
expenses of running a business (organization) and the opportunity cost of capital. Also, with its
emphasis on operating profit less capital costs, EVA—more aptly, the discounted value thereof-is a direct measure of whether or not a healthcare provider is a value creator (discounted positive
EVA) or a value destroyer.
Providers should be cautioned that EVA measurement does not imply that accounting
profit measurement is irrelevant. Indeed, several accounting items such as Net Revenue, COMS,
and SG&A are included in the estimation of a provider’s NOPAT. Also, accounting profit
already includes the pre-tax and after-tax interest cost on a provider’s debt. However, this is
where the similarities between EVA and accounting profit end since EVA links both the income
statement and balance sheet in a way that fully reflects the dollar cost of all sources of financing,
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particularly the dollar cost of equity in the For Profit setting and the cost of fund equity in the
case of Not-For-Profit providers.
This conceptual difference in profit measurement is poignant for companies (providers or
otherwise) in sectors like healthcare and (bio) technology that tend to finance their growth
opportunities with equity rather than debt. For these sectors, the EVA formula can be used to
show that the weighted average cost of debt and equity, WACC, is in fact the cost of equity.
Surely, equity (or fund equity) capital is not a “free” source of financing for any provider as
accounting profit measures such as net operating income (For-Profit and Not-for-Profit settings)
and earnings per share (For-Profits) might mistakenly suggest.
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Exhibit 1
OK Health Provider
Income Statement

Status Quo
Position

Revenue

$125,000

COMS*

86,000

Gross Income
SG&A
Operating Income
Interest Expense
Pretax Profit
Taxes (at 40%)
Net Income

Shares Outstanding
EPS

$39,000
22,000
$17,000
3,312
13,688
5,475
$ 8,213

6,250
$ 1.31

*COMS=Cost of Medical Services
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Exhibit 2
OK Health Provider
Balance Sheet

Cash

7,000

Accounts Payable

Securities

8,000

Wages Payable

2,000

Accounts Receivable

14,000

Tax Accruals

2,000

Inventory

53,000

Current Liabilities

Current Assets

82,000

(non-interest bearing)

Property

4,000

Long-term Debt

Net Plant

15,000

(8% Coupon)

Net Equipment

51,000

Net Fixed Assets

70,000

10,000

14,000

41,400

Common Stock at Par

625

(par value $.10; 6250
shares auth./outstanding)
Addit. Paid in Capital
Retained Earnings

14,375

81,600

Stockholders’ Equity*

96,600

Liabilities and
Total Assets

152,000

Stockholders Equity

152,000

*As a Not-for-Profit provider, OK-Health’s $96,600 in stockholders’ equity account would
generally consist of three (rather non-descript) accounts: (1) Un-restricted net assets (in effect,
retained earnings), (2) temporarily restricted net assets, and (3) permanently restricted net assets.

29

Exhibit 3
OK Health Provider
Basic Operating and Financial Capital
(Aggregate Results)

Operating Capital (basic):

Financing Capital (basic):

Net Working Capital
Current Assets
Current Liabilities
(non-interest bearing)

Net Fixed Assets

Totals:

82,000
(14,000)
_____
68,000

Long Term Debt

41,400

70,000

Stockholder’s Equity

96,600

138,000

138,000
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Exhibit 4: Calculation of Provider Disclosed NOPAT
from Financial Statement Data
Panel A. Bottom-up approach
Begin:
Operating profit after depreciation and amortization
Add:
Implied interest expense on operating leases
Increase in LIFO reserve
Increase in accumulated goodwill amortization
Increase in capitalized research and development
Increase in cumulative write-offs of special items
Increase in bad debt reserve (financially adequate payers)
Increase in capitalized net charity care
Increase in capitalized medical training programs
Increase in capitalized community wellness programs
Equals:
Adjusted operating profit before taxes
Subtract:
Cash operating taxes
Equals:
NOPAT (disclosed)
Panel B. Top-down approach
Begin:
Net Sales
Subtract:
Cost of goods sold
Selling, general, and administrative expenses
Depreciation
Add:
Implied interest expense on operating leases
Increase in equity reserve accounts (see above listing)
Other operating income
Equals:
Adjusted operating profit before taxes
Subtract:
Cash operating taxes
Equals:
NOPAT (disclosed)
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Exhibit 5: Calculation of Provider Disclosed Capital
from Financial Statement Data
Panel A. Assets approach
Begin:
Net short-term operating assets*
Add:
Net plant, property, and equipment
Other assets
Goodwill (acquisitions)
LIFO reserve
Accumulated goodwill amortization
Capitalized research and development
Cumulative write-offs of special items
Bad-debt reserve (financially adequate payers)
Capitalized net charity care
Capitalized medical training programs
Capitalized community wellness programs
Present value of operating leases
Equals:
Capital (disclosed)
Panel B. Sources of financing approach
Begin:
Book value of common equity
Add equity equivalents:
Preferred stock
Minority interest
Deferred income tax
Equity reserve accounts (see above listing)
Add debt and debt equivalents:
Interest bearing short-term debt
Current portion of long-term debt due
Long-term debt
Capitalized lease obligations
Present value of operating leases
Equals:
Capital (disclosed)
*Net short-term operating assets = Current Assets less Current Liabilities (excluding debt-related
short-term liabilities)
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1

EVA® is a registered trademark of Stern Stewart & Co. While this primer emphasizes the role of economic profit
(EVA) in creating value, the methodology could be used as part of a more general “balanced scorecard” approach,
with EVA analyses substituting for more traditional ways (margins, ROI, ROE) of measuring provider financial
performance.
2
For example, as of 2002, Not-for-Profit (and voluntary) hospitals accounted for some 61% of community hospitals
in the United States. For-Profit or investor owned hospitals made up about 15% of the total while state and local
government community hospitals, at 24% accounted for the balance (Health, United States, 2002, p. 279).
3
See Stewart (1991).
4
In principle, charity care costs can be viewed as an intangible asset that is central to the community service mission
of healthcare providers, particularly hospitals and clinics. The phrase “net charity care” is used to recognize that this
intangible arises from voluntary expenditures made by providers over-and -above required contributions to a state
uncompensated care pool or those made simply to preserve the tax-exempt status of a Not-for-Profit provider.
Hence, net (or excess) charity care is a truly voluntary contribution that enhances one’s brand image. Moreover,
providers should distinguish between net charity care and bad debt expense, where in the latter case an individual is
deemed financially able to pay, yet unwilling to do so. We’ll say more on charity care and related intangibles such
as community wellness and prevention program costs at a later point.
5
Unlike For-Profit providers, the concept of “equity” for a Not-for-Profit provider is rather vague. Conventional
accounting uses the term “net assets” on the balance sheet of Not-for-Profit providers to represent the difference
between assets and liabilities. In the For-Profit case, the difference between asset and liability accounts is the
familiar Stockholders’ Equity account. Moreover, the net asset account for Not-for-Profits can be separated into
three other non-descript labels: unrestricted net assets (in effect, retained earnings), temporarily restricted net assets,
and permanently restricted net assets. See, for example, Partners HealthCare annual reports at www.partners.org.
In this EVA primer, we’ll use the term “fund equity” to represent the overall net asset account of Not-for-Profit
providers. This terminology makes a connection with the For-Profit concept of equity in that donors have
contributed risk capital to providers. In turn, risk capital has an opportunity cost (or required return) just like equity
capital in the For-Profit setting. This reflects equity capital costs on both donor contributions to providers and the
buildup (or builddown in the event of losses) of retained earnings in the unrestricted net asset account.
6
For a complete discussion of EVA, see Grant (2003).
7
In effect, “t” is an unlevered tax rate because EVA equals NOPAT less cash taxes free of any debt tax subsidies.
This is relevant for For-Profit providers.
8
This section draws on EVA application from Grant (2003); recast with application to For-Profit and Not-for-Profit
healthcare providers.
9
The assumed margins are actually higher than the 3-4% median margins observed for hospitals over the 1998 to
2003 period. For example, median operating margins for Massachusetts hospitals range from about -1% to 0%
during this six-year period. See Hayden (2005).
10
For analysis of healthcare providers using traditional metrics, such as operating margins, turnover ratios, and rate
of return metrics (ROA, ROI, and ROE), see Gapenski (2003). See also Carlson (2005) for recent insights on how to
use balance sheet management and structured (tax-exempt) debt products as a way of enhancing the visibility of
providers to investors. In this EVA primer for healthcare providers, we emphasize a value proposition for enticing
investors via positive economic earnings as reflected in the difference between a provider’s operating earnings and
its dollar cost of capital (or positive spread between return on capital and cost of capital).
11
For convenience, we’ll assume that depreciation on medical facilities and equipment is included in the SG&A
account. Without getting into EVA details, one could also distinguish between accounting depreciation and
economic depreciation.
12
We’ll discuss how to calculate the cost of capital for a Not-for-Profit provider following our discussion of a ForProfit. By their namesake, Not-for-Profits do not pay taxes (strictly speaking) so there are no tax subsidies arising
from asset depreciation and interest expense on debt financing. However, the cost of equity, more aptly, “fund
equity” needs to be grossed up by (1-t).
13
See Sharpe (1964). Also, the “just right” way of calculating a company’s cost of equity has come under several
empirical challenges. For example, see Fama and French (1992). However, it should be noted that the validity of the
EVA model does not require that asset prices are set according to the single (beta)-factor CAPM.
14
The cost of equity for a Not-for-Profit provider, referred to as “fund” equity, deserves special attention which
we’ll discuss in a later section.
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15

Persistently negative EVA leads to negative NPV (value destruction).
The spread between ROC and WACC is commonly referred to as the “EVA spread.” If goodwill (arising from
premiums paid in corporate acquisitions under purchase accounting) is listed on a provider’s balance sheet, then one
can distinguish between the operating return on capital and the total return on capital. As Peterson emphasizes
(2000), the appropriate capital return measure depends on whether managers are interested in measuring the firm’s
operating efficiency-which calls for using the former profit ratio-or the efficiency of management in using total
capital-given perhaps an acquisitions strategy which would call for using the latter ratio. Also, which capital
measure to use is poignant for healthcare providers if one treats charity care and related medical intangibles as key
to fulfilling a community service mission.
17
As noted before, the difference between assets and liabilities for Not-for-Profit providers is often called “net
assets.” We’ll replace this rather non-descript terminology with the words “fund equity” for reasons cited before.
18
The growth opportunity figures are expressed for OK Health as a For Profit provider. To obtain the corresponding
change in EVA for a Not-for-Profit, simply “gross up” (or divide) the after-tax change in EVA by (1-t).
19
This applies to OK Health as a For Profit provider. As a Not-for Profit provider, we interpret equity contributors
(grantors and donors) as fund equity holders (investors).
20
See Grant (2003).
21
The first four ways of improving EVA are consistent with those mentioned by Tully (1993).
22
The positive impact of tax efficiency applies only in the For-Profit setting.
23
Alfred Marshall (1890, p. 142) is often cited for the economist’s notion that “profit” should be reflect opportunity
costs (and benefits).
24
Stewart (1991).
25
Net operating profit before taxes (EBIT) is also the same as operating profit after depreciation and amortization.
26
In other words, R&D expenditures should be capitalized and amortized over a useful time period such as five
years—rather than expensed in the current year as if these expenditures have no future cash flow benefits. For
example, if R&D expenditures for a given year were $100,000, then $80,000 would be placed on the EVA balance
sheet (at year end) and the remaining $20,000 would be charged to income. Assuming the entire R&D investment
were already included in a Selling, General and Administrative expenses account, then the net R&D increase of
$80,000 would get added back to obtain the EVA amortization of R&D expenditures, at $20,000. A similar EVA
treatment would apply to medical intangibles, unique to healthcare providers.
27
The normal amount of cash required for operations varies by industry—say 0.5% to 2% of net sales. As noted
before, one can make a distinction between total invested capital and operating capital. Operating capital is generally
viewed as invested capital net of excess cash and marketable securities and goodwill-related accounts. In principle,
excess cash could be used to pay down debt; in that event, EVA debt would be interpreted as net debt.
28
In practice, it may be better to list the capitalized value of net charity care and like expenditures that are part of a
provider’s mission as “equity equivalents” (mentioned next).
29
The EVA recognition of “off balance sheet” debt brings up an interesting issue. While EVA accounting uses
information that is deemed accurate from a company’s published financial reports—including income statement,
balance sheet, and relevant footnotes, EVA like accounting profit cannot possibly reflect “off balance sheet” debts
arising from hidden liabilities or fraudulent accounting transactions as in the notorious case of Enron.
16
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